There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Bronchial asthma is a true ascending clinical problem. Angiotensin II is now accused
to be potentially implicated in its pathogenesis, being a potent pro-inflammatory
mediator with remodeling effects.